Analyst Ratings for Anacor Pharmaceuticals (ANAC)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2016 | Mizuho | N/A | Downgrade | Neutral (Outperform) |
99.25 (98.00) |
99.99 (10.19) |
-89.81% | Details |
| 5/17/2016 | Wedbush | N/A | Downgrade | Neutral (Outperform) |
99.25 (148.00) |
100.67 (10.19) |
-89.88% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


